-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Pfizer, Raises Price Target to $33

Benzinga·11/05/2026 15:57:29
Listen to the news
Guggenheim analyst Vamil Divan maintains Pfizer (NYSE:PFE) with a Buy and raises the price target from $31 to $33.